Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In MacroGenics To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in MacroGenics between March 7, 2024 to May 9, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330(Ext. 1310).
[You may also click here for additional information]
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against MacroGenics, Inc. (“MacroGenics” or the “Company”) (NASDAQ: MGNX) and reminds investors of the September 24, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
https://mma.prnewswire.com/media/2457438/Faruqi_Logo.jpg
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the safety data from its TAMARACK Phase 2 study of vobramitamab duocarmazine.
On May 9, 2024, the investing public learned that the drug was significantly more dangerous than defendants had previously represented.
Following this news, MGNX’s stock declined 77.4% due to a drop of $11.36/share.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding MacroGenic’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the MacroGenics class action, go to www.faruqilaw.com/MGNX or callFaruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330(Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
https://mma.prnewswire.com/media/1959220/Logo_11_30_2022.jpg
https://c212.net/c/img/favicon.png?sn=NY12175&sd=2024-09-23
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-action-reminder-faruqi–faruqi-llp-investigates-claims-on-behalf-of-investors-of-macrogenics-302254728.html
SOURCE Faruqi & Faruqi, LLP
https://rt.newswire.ca/rt.gif?NewsItemId=NY12175&Transmission_Id=202409230945PR_NEWS_USPR_____NY12175&DateId=20240923
COMTEX_458074160/1005/2024-09-23T09:45:29